[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Pharmaceuticals Company Research Reports

Pharmaceuticals companies are involved into development, production as well as marketing of an extensive variety of medicines. The pharmaceuticals industry is represented by innumerable companies. Small biotechnology and biopharmaceutical manufacturers, mid-sized specialty companies, large multi-nationals enterprises are amid the world pharma companies.

Appearance of new products; introduction of new product costs structures and modes of healthcare delivery; modification of product cost, offerings and design; growing public scrutiny; scientific researches in the fields of nanotechnology, bioengineering, etc. are among trends contributing to changes in the pharmaceutical industry.

Johnson & Johnson, Pfizer, Inc., Roche Holding AG, Novartis International AG, Abbott Laboratories, etc. are amid behemoths of the pharmaceutical industry.

Within this MarketPublishers’ catalogue there are innumerable reports featuring pharmaceutical companies’ overviews. The research reports provide a state-of-the-art picture of the pharma market including the analyses of the pharmaceuticals companies. Evaluation of companies’ strategies and data on products offerings are available in the research studies.

Publications found: 3,987
Sort by:

Arturus Capital Limited. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Arturus Capital Limited. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Arvind Remedies Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Arvind Remedies Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

ARYx Therapeutics, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

ARYx Therapeutics, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

AS Olainfarm Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

AS Olainfarm Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Avidus Management Group Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Avidus Management Group Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Ascent Pharmahealth Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Ascent Pharmahealth Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Asia Resources Holdings Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Asia Resources Holdings Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

ASKA Pharmaceutical Co.Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

ASKA Pharmaceutical Co.Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 71 pages

Aspen Pharmacare Holdings Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Aspen Pharmacare Holdings Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

AspenBio Pharma Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

AspenBio Pharma Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Astellas Pharma, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Astellas Pharma, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Asterand Plc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Asterand Plc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Astralis Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Astralis Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

AstraZeneca Pharma India Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

AstraZeneca Pharma India Limited Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

AstraZeneca PLC Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

AstraZeneca PLC Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Atheronova, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Atheronova, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Athersys, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Athersys, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Aureum Realwert AG Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Aureum Realwert AG Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Auriga Laboratories Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Auriga Laboratories Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Auro Laboratories Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Auro Laboratories Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Aurobindo Pharma Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Aurobindo Pharma Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

AutoImmune Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

AutoImmune Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Auxilium Pharmaceuticals Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Auxilium Pharmaceuticals Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Avanir Pharmaceuticals Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Avanir Pharmaceuticals Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Avantogen Oncology, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Avantogen Oncology, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

AVAX Technologies Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

AVAX Technologies Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Aventis Pharma Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Aventis Pharma Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

AVEO Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

AVEO Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Averion International Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Averion International Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Novita Healthcare Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Novita Healthcare Limited Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

AVI Biopharma, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

AVI Biopharma, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Avita Medical Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Avita Medical Limited Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Avvaa World Health Care Products Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Avvaa World Health Care Products Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Axiogenesis AG Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Axiogenesis AG Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 52 pages

AXM Pharma Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

AXM Pharma Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Ayrton Drugs Manufacturing Company Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Ayrton Drugs Manufacturing Company Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Bachem Holding AG Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Bachem Holding AG Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Xtant Medical Holdings Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Xtant Medical Holdings Inc Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Bafna Pharmaceuticals Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Bafna Pharmaceuticals Limited Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

BAL Pharma Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

BAL Pharma Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Basilea Pharmaceutica AG Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Basilea Pharmaceutica AG Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Bavarian Nordic A/S Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Bavarian Nordic A/S Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Bayer AG Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Bayer AG Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

BCY Resources Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

BCY Resources Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

BDH Industries Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

BDH Industries Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Bedminster National Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Bedminster National Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Beijing Beilu Pharmaceuticals Company Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Beijing Beilu Pharmaceuticals Company Limited Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Beijing Double-Crane Pharmaceutical Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Beijing Double-Crane Pharmaceutical Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Beijing SL Pharmaceutical Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Beijing SL Pharmaceutical Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Beijing Tiantan Biological Products Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Beijing Tiantan Biological Products Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

April 2024 50 pages

Filters

Search

Publishers

2,237
1,678
37
6
2
1
1
21
2
1
1

Regions

1,352
441
361
240
234
179
155
127
100
90
84
73
65
62
44
27
27
24
20
19
19
19
19
18
17
15
14
13
12
11
11
8
7
7
6
5
5
5
5
4
3
2
2
2
2
2
2
2
2
2
2
2
2
1
1
13

Price

Date

Pages

Offers